Eli Lilly / Pfizer / Alexion / Novartis / Duke Cancer Care Research Program / Amgen / Nationwide / US Agency for Healthcare Research / /
Country
Puerto Rico / United States / /
Currency
USD / / /
Facility
National Cancer Institute / The National Cancer Institute / Research Triangle Institute / Duke University Medical Center / Duke Cancer Institute / / /
IndustryTerm
cancer prevention / Cancer Therapy / Cancer Care / cancer treatment / healthcare / /
MedicalTreatment
Cancer Therapy / /
Organization
Division of Medical Oncology / Duke University / National Cancer Institute / Affiliations Department of Medicine / Duke Cancer Institute Durham / Duke University School of Medicine / NCI NIH / Robert Wood Johnson Foundation / Research Triangle Institute / office of Management and Budget / US Agency for Healthcare Research and Quality / Duke University Medical Center / /
Person
Amy P. Abernethy / Robert Wood / / /
Position
Investigator / Chief Operating Officer / CEO / Chief Executive Officer / Professor of Medicine1 / 2 Susan C. Locke / Executive / Nurse / analyst / COO / Associate Professor / Research Associate / Corresponding author / /
The Relationship between Participation in the National Cancer Institute’s Community Cancer Centers Program (NCCCP) and Clinical Trials Activity